Eichenlaub, M.; Arlt, J.; Steigert, J.; Arlt, S.; Yassouridis, A.; Jahn, H.: The influence of galantamine on heart rate variability (HRV). Pharmacopsychiatry 42 (5), p. 217 - 217 (2009)

Filiou, M. D.; Zhang, Y. Y.; Bisle, B.; Frank, E.; Kessler, M. S.; Teplytska, L.; Reckow, S.; Haegler, K.; Maccarrone, G.; Hambsch, B. et al.; Landgraf, R.; Turck, C. W.: Stable isotope metabolic labeling of a mouse model reveals synaptic biomarkers for anxiety disorders. Pharmacopsychiatry 42 (5), p. 217 - 217 (2009)

Gassen, N.; Han, Y.; Rein, T.: Functional impact of FKBP5 on the phosphatase calcineurin. Pharmacopsychiatry 42 (5), pp. 217 - 218 (2009)

Golub, Y.; Mauch, C. P.; Pamplona, F.; Wotjak, C. T.: The role of time-dependent memory processes in the development of PTSD-like symptoms in mice. Pharmacopsychiatry 42 (5), p. 219 - 219 (2009)

Gorshtein, A.; Rubinfeld, H.; Kendler, E.; Theodoropoulou, M.; Cerovac, V.; Stalla, G. K.; Cohen, Z. R.; Hadani, M.; Shimon, I.: Mammalian target of rapamycin inhibitors rapamycin and RAD001 (everolimus) induce anti-proliferative effects in GH-secreting pituitary tumor cells in vitro. Endocrine-Related Cancer 16 (3), pp. 1017 - 1027 (2009)

Goya-Maldonado, R.; Spoormaker, V. I.; Chechko, N.; Höhn, D.; Andrade, K.; Kluge, M.; Steiger, A.; Holsboer, F.; Czisch, M.; Sämann, P. G.: Subregional amygdala functional connectivity: normative maps and influence of oral citalopram in healthy volunteers. Pharmacopsychiatry 42 (5), p. 219 - 219 (2009)

Hartmann, J.; Wagner, K.; Liebl, C.; Wolf, M.; Scharf, S.; Wang, X. D.; Harbich, D.; Mayer, B.; Rein, T.; Schmidt, U. et al.; Hausch, F.; Smith, D.; Cox, M. B.; Müller, M. B.; Schmidt, M. V.: The involvement of FKBP5 in the behavioural and neuroendocrine effects of acute and chronic stress. Pharmacopsychiatry 42 (5), p. 221 - 221 (2009)

Heck, A.; Szesny, N.; Holsboer, F.; Reppermund, S.; Ising, M.: Polymorphisms of the dopamine beta-hydroxylase (DBH) gene show associations with cognitive flexibility in mentally healthy adults. Pharmacopsychiatry 42 (5), p. 221 - 221 (2009)

Heinzmann, J. M.; Thöringer, C. K.; Palme, R.; Landgraf, R.; Touma, C.: Temporal aspects of HPA axis reactivity and regulation: microdialysis studies in the HR/IR/LR mouse model. Pharmacopsychiatry 42 (5), p. 221 - 221 (2009)

Henes, K.; Wotjak, C. T.: Traces of a trauma - Long-lasting changes in brain activity in an animal model of PTSD. Pharmacopsychiatry 42 (5), p. 222 - 222 (2009)

Hennings, J. M.; Owashi, T.; Binder, E. B.; Horstmann, S.; Menke, A.; Kloiber, S.; Messer, T.; Pollmächer, T.; Nickel, T.; Sonntag, A. et al.; Uhr, M.; Ising, M.; Holsboer, F.; Lucae, S.: Clinical characteristics and treatment outcome in a representative sample of depressed inpatients - Findings from the Munich Antidepressant Response Signature project. Pharmacopsychiatry 42 (5), p. 222 - 222 (2009)

Hinkelmann, K.; Yassouridis, A.; Mass, R.; Tenge, H.; Kellner, M.; Jahn, H.; Wiedemann, K.; Wolf, K.: CCK-4 effects upon facial expression in healthy subjects. Pharmacopsychiatry 42 (5), p. 222 - 222 (2009)

Höhn, D.; Spoormaker, V. I.; Czisch, M.; Sämann, P. G.: FMRI based resting state networks challenged as predictors of stress coping styles and personality traits in healthy volunteers. Pharmacopsychiatry 42 (5), p. 223 - 223 (2009)

Holfelder, C.; Eder, M.; Becker, K.; Zieglgänsberger, W.; Buchwald, B.: Semicarbazide modulates cortical excitation in mouse brain slices. Pharmacopsychiatry 42 (5), p. 223 - 223 (2009)

Horstmann, S.; Menke, A.; Hennings, J. M.; Lucae, S.; Straub, V.; Spieler, D.; Wollweber, B.; Holsboer, F.; Binder, E. B.: Association of the adrenergic receptor alpha1B with antidepressant treatment in the MARS study. Pharmacopsychiatry 42 (5), p. 223 - 223 (2009)

Ising, M.; Lucae, S.; Binder, E. B.; Bettecken, T.; Uhr, M.; Ripke, S.; Kohli, M. A.; Hennings, J. M.; Horstmann, S.; Kloiber, S. et al.; Menke, A.; Bondy, B.; Rupprecht, R.; Domschke, K.; Baune, B. T.; Arolt, V.; Rush, A. J.; Holsboer, F.; Müller-Myhsok, B.: A Genomewide Association Study Points to Multiple Loci That Predict Antidepressant Drug Treatment Outcome in Depression. Archives of General Psychiatry 66 (9), pp. 966 - 975 (2009)

Ising, M.; Lucae, S.; Binder, E. B.; Bettecken, T.; Uhr, M.; Ripke, S.; Kohli, M. A.; Hennings, J. M.; Horstmann, S.; Kloiber, S. et al.; Menke, A.; Bondy, B.; Rupprecht, R.; Domschke, K.; Baune, B. T.; Arolt, V.; Rush, A. J.; Holsboer, F.; Müller-Myhsok, B.: A genome-wide association study points to multiple loci predicting antidepressant treatment outcome in depression. Pharmacopsychiatry 42 (5), p. 224 - 224 (2009)

Jaffrain-Rea, M. L.; Angelini, M.; Gargano, D.; Tichomirowa, M. A.; Daly, A. F.; Vanbellinghen, J. F.; D'Innocenzo, E.; Barlier, A.; Giangaspero, F.; Esposito, V. et al.; Ventura, L.; Arcella, A.; Theodoropoulou, M.; Naves, L. A.; Fajardo, C.; Zacharieva, S.; Rohmer, V.; Brue, T.; Gulino, A.; Cantore, G.; Alesse, E.; Beckers, A.: Expression of aryl hydrocarbon receptor (AHR) and AHR-interacting protein in pituitary adenomas: pathological and clinical implications. Endocrine-Related Cancer 16 (3), pp. 1029 - 1043 (2009)

Kaltwasser, S. F.; Golub, Y.; Mauch, C. P.; Czisch, M.; Wotjak, C. T.: Reduction of hippocampal volume after traumatic experience can be prevented by enriched environment. Pharmacopsychiatry 42 (5), p. 225 - 225 (2009)

Kellner, M.; Muhtz, C.; Demiralay, C.; Husemann, J.; Koelsch, W.; Yassouridis, A.; Wiedemann, K.: Serotonergic modulation of experimental panic elicited by cholecystokinin tetrapeptide in healthy man. Pharmacopsychiatry 42 (5), p. 225 - 225 (2009)